Skip to Main Content

Paper Details

Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
Nat Commun
2
2023
Author NameAffiliation
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Anne-Claude GingrasUniversity of Toronto
  • 1 - 2

Datasets

Release 1.2